Items tagged with Drug-resistant TB
Armenia: Tackling drug-resistant TB (post)
"I thought I would definitely die, I lost all hope", says Arman, a thirtyfive year-old ex-soldier from Armenia.
Kenyan concerns about rising MDR-TB reflect regional public health challenge (post)
Kenya has made enormous strides in its efforts to tackle tuberculosis amongst its population, improving diagnosis and treatment to such an extent that prevalence has dropped from 335 to 299 cases per 100,000 people between 2006 and 2012. But the continuing insecurity in the region backed by the weakness of the health infrastructure in neighboring countries have maintained the flow of refugees into Kenya, and into the national health system in search of treatment and care.
Government of India and World Bank sign $100 million agreement for accelerating universal access to early and effective tuberculosis care in India (post)
The project will contribute to the care of about 3.1 million TB patients, increase treatment for MDR-TB to 40,000 patients annually, and reach 90,000 pediatric TB cases annually
Incorrect medication worsens drug-resistant TB (post)
Experts are concerned that we’re running into an era where we don’t have drugs available because organisms have developed resistance to these drugs.
South Africa: GeneXpert’s benefits still not reaching patients (post)
The Department of Health’s multi-million rand investment in an automated, rapid TB test is being short-changed by slow health systems, said researchers this week.
USP helps expand worldwide access to key tuberculosis drugs (post)
Rockville, Md., June 10, 2014 — The US Pharmacopeial Convention (USP) is pleased to announce that with the assistance of the U.S. Agency for International Development (USAID) funded Promoting the Quality of Medicines (PQM) program, the first Active Pharmaceutical Ingredient (API) for injectables used in the treatment of multi-drug resistant tuberculosis has been assessed by the World Health Organization and given prequalification status. The prequalification of Capreomycin, the first “second line” anti-tuberculosis API for injectables to achieve this status, is a significant development in the global fight against one of the world’s most prevalent and deadly diseases.
A new partnership to change MDR-TB treatment around the world (post)
Multidrug-resistant tuberculosis (MDR-TB) is one of the most serious public health problems in the world today—and the global burden is growing. That’s why we are delighted to announce that UNITAID has awarded Partners In Health a grant that will change how MDR-TB is treated throughout the world.
South Africa: Government to introduce new drug-resistant TB drugs (post)
Government’s small-scale introduction of the first new TB drug in four decades is saving lines and paving the way for more, better and cheaper drugs to treat drug-resistant TB. Many wonder if they will come fast enough for those who need them.
DR-TB focus in new NSP Review (post)
The latest issue of the TAC/SECTION27 NSP Review has a focus on DR-TB.
Roll-out of new TB drug must be handled with care (post)
Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson, has announced that it will make its breakthrough new tuberculosis (TB) drug, Sirturo, available at a discount in 130 developing countries. As the first new antibiotic to be approved to treat TB in over 40 years, Sirturo will be an important new weapon in the aging arsenal of medicines used to treat this deadly disease.
Page 5 of 117 · Total posts: 0
←First 4 5 6 Last→